Syntel to Announce Fourth Quarter and Full Year 2016 Results on Thursday, February 16, 2017
Feb 10, 2017 13:30 pm UTC| Business
TROY, Mich., Feb. 10, 2017 -- Syntel, Inc. (Nasdaq:SYNT), a leading global provider of integrated information technology and knowledge process services, will announce results for the Fourth Quarter and Full Year 2016,...
Ultragenyx to Present at Leerink Partners Global Healthcare Conference
Feb 10, 2017 13:30 pm UTC| Business
NOVATO, Calif., Feb. 10, 2017 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Shalini...
Atrium Mortgage Investment Corporation Completes $30 Million Public Offering of Common Shares
Feb 10, 2017 13:27 pm UTC| Business
TORONTO, Feb. 10, 2017 -- Atrium Mortgage Investment Corporation (TSX:AI) is pleased to report that it has closed its previously announced public offering of common shares for gross proceeds of $30,039,750 with a...
Advantys Announces the Adoption of GraphQL for its WorkflowGen Workflow Software API
Feb 10, 2017 13:03 pm UTC| Business
Montreal, Feb. 10, 2017 -- Advantys is among the very first BPM and workflow software vendors to adopt GraphQL for its WorkflowGen API. With GraphQL, developers have control over data they want to manipulate and...
Feb 10, 2017 13:02 pm UTC| Business
ARLINGTON, Va., Feb. 10, 2017 -- FBR Co. (NASDAQ:FBRC) ("FBR" or the “Company"), a leading investment bank serving the middle market, today reported pre-tax income of $5.2 million on revenues of $40.2 million, and a...
Feb 10, 2017 13:02 pm UTC| Business
BRIDGEWATER, N.J., Feb. 10, 2017 -- Valeritas Holdings, Inc. (OTCQB:VLRX) announced today that the Company will release its fourth quarter and full year 2016 financial results on Tuesday, February 21, 2017 before the...
iTeos Therapeutics to Present at the 2017 BIO CEO & Investor Conference
Feb 10, 2017 13:01 pm UTC| Business
iTeos Therapeutics to Present at the 2017 BIO CEO Investor Conference Gosselies, Belgium - February 10, 2017 - iTeos Therapeutics SA, a Belgian privately-held biotechnology company applying its expertise in...